These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The efficacy and safety of itopride in feeding intolerance of critically ill patients receiving enteral nutrition: a randomized, double-blind study. Elmokadem EM; El Borolossy RM; Bassiouny AM; Hanna MG; Darweesh EAG; Sabri NA BMC Gastroenterol; 2021 Mar; 21(1):126. PubMed ID: 33740892 [TBL] [Abstract][Full Text] [Related]
9. Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance. Chapman MJ; Jones KL; Almansa C; Barnes CN; Nguyen D; Deane AM JPEN J Parenter Enteral Nutr; 2021 Jan; 45(1):115-124. PubMed ID: 31990087 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying feed intolerance in the critically ill: implications for treatment. Deane A; Chapman MJ; Fraser RJ; Bryant LK; Burgstad C; Nguyen NQ World J Gastroenterol; 2007 Aug; 13(29):3909-17. PubMed ID: 17663503 [TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial. Heyland DK; van Zanten ARH; Grau-Carmona T; Evans D; Beishuizen A; Schouten J; Hoiting O; Bordejé ML; Krell K; Klein DJ; Gonzalez J; Perez A; Brown R; James J; Harris MS; Intensive Care Med; 2019 May; 45(5):647-656. PubMed ID: 31062046 [TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials. Lewis K; Alqahtani Z; Mcintyre L; Almenawer S; Alshamsi F; Rhodes A; Evans L; Angus DC; Alhazzani W Crit Care; 2016 Aug; 20(1):259. PubMed ID: 27527069 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal Dysfunction and Feeding Intolerance in Critical Illness: Do We Need an Objective Scoring System? McClave SA; Gualdoni J; Nagengast A; Marsano LS; Bandy K; Martindale RG Curr Gastroenterol Rep; 2020 Jan; 22(1):1. PubMed ID: 31912312 [TBL] [Abstract][Full Text] [Related]
14. Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient. Fraser RJ; Bryant L Nutr Clin Pract; 2010 Feb; 25(1):26-31. PubMed ID: 20130155 [TBL] [Abstract][Full Text] [Related]
15. Effect of Daikenchuto for Mechanically Ventilated Patients With Enteral Feeding Intolerance: A Propensity Score-Matched Analysis Using a Nationwide Administrative Inpatient Database. Ohbe H; Jo T; Matsui H; Fushimi K; Yasunaga H JPEN J Parenter Enteral Nutr; 2021 Nov; 45(8):1703-1713. PubMed ID: 33483948 [TBL] [Abstract][Full Text] [Related]
16. Enteral feeding intolerance: an indicator of sepsis-associated mortality in burned children. Wolf SE; Jeschke MG; Rose JK; Desai MH; Herndon DN Arch Surg; 1997 Dec; 132(12):1310-3; discussion 1313-4. PubMed ID: 9403535 [TBL] [Abstract][Full Text] [Related]
17. Comparison of different definitions of feeding intolerance: A retrospective observational study. Reintam Blaser A; Starkopf L; Deane AM; Poeze M; Starkopf J Clin Nutr; 2015 Oct; 34(5):956-61. PubMed ID: 25467878 [TBL] [Abstract][Full Text] [Related]
18. Gastric Dysmotility in Critically Ill Children: Pathophysiology, Diagnosis, and Management. Martinez EE; Douglas K; Nurko S; Mehta NM Pediatr Crit Care Med; 2015 Nov; 16(9):828-36. PubMed ID: 26218259 [TBL] [Abstract][Full Text] [Related]
19. Gastroparesis in the intensive care unit. Stojek M; Jasiński T Anaesthesiol Intensive Ther; 2021; 53(5):450-455. PubMed ID: 34816707 [TBL] [Abstract][Full Text] [Related]
20. Intolerance to intragastric enteral nutrition in critically ill patients: complications and management. MacLaren R Pharmacotherapy; 2000 Dec; 20(12):1486-98. PubMed ID: 11130221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]